COPD clinical trials
- Phase
- Phase 4
- Phase
- Phase 1
- Phase
- Phase 3
Access comprehensive clinical trial information for COPD through Pure Global AI's free database. This collection includes 746 clinical trials across multiple phases including N/A, Phase 4, Phase 2. Currently, 131 trials are actively recruiting participants.
Research for COPD is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include AstraZeneca and Chiesi Farmaceutici S.p.A.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 746 clinical trials studying COPD, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Chiesi Farmaceutici S.p.A., Pearl Therapeutics, Inc., among others.